Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals

Clinical trial NCT04207840 · COMPLETED

Trial details

NCT number: NCT04207840
Sponsor: Amphastar Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pharmacokinetics Epinephrine Albuterol Asthma Anaphylaxis

Start date: 2019-12-09
Primary completion: 2019-12-20
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.